Clinical adrenal insufficiency in patients receiving megestrol therapy.
Arch Intern Med
; 157(9): 1008-11, 1997 May 12.
Article
em En
| MEDLINE
| ID: mdl-9140272
ABSTRACT
OBJECTIVE:
To describe the clinical and biochemical features of patients in whom adrenal insufficiency developed during megestrol acetate therapy for advanced breast cancer. PATIENTS ANDMETHODS:
Thirteen patients with advanced breast cancer treated with oral megestrol acetate, 160 mg/d.RESULTS:
Fatigue and weakness were observed in all 13 patients. Hypotension was observed in 8. Anorexia, nausea, vomiting, and diarrhea were observed in 3. Mean basal cortisol level at the time of symptoms was 41.4 nmol/L (range, 27.6-110.4 nmol/L). After corticotropin stimulation, mean cortisol level at 30 minutes was 239.2 nmol/L (range, 93.8-447.0 nmol/L); at 60 minutes, 228.2 nmol/L (range, 88.3-474.5 nmol/L).CONCLUSION:
Megestrol therapy was associated with the development of clinical adrenal insufficiency in our patients, as proved by rapid corticotropin test.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Mama
/
Hidrocortisona
/
Glândulas Suprarrenais
/
Antineoplásicos Hormonais
/
Acetato de Megestrol
Limite:
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
1997
Tipo de documento:
Article